Company
Figur8
FIGUR8 is the first FDA-registered accurate, objective musculoskeletal (MSK) assessment that’s practical for every point of care.
Also known as FIGUR8, INC.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- clinicians, providers and payers
- Legal name
- FIGUR8, INC.
- figur8tech.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
FIGUR8 is redefining musculoskeletal (MSK) care with our proprietary Biomotion Assessment Platform, delivering objective, data-driven insights to optimize recovery, enhance outcomes, and support clinical decision-making.
Funding snapshot
- Total raised
- $33.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $24.6M2023-07-25
Funding rounds
- Round, 2023
- $24.6M2023-07-25, SEC form D sold, 18 investors
- Round, 2020
- $6.2M2020-11-03, SEC form D sold, 14 investors
- Round, 2020
- $1.5M2020-02-12, SEC form D sold, 6 investors
- Round, 2017
- $825K2017-01-09, SEC form D sold, 3 investors
Products
- Hardware
- bioMotion Assessment Platform (bMAP)
Loading relationship preview